Home
Home

OTC

Novartis Unloads OTC Products Made At Troubled Nebraska Plant

Novartis Unloads OTC Products Made At Troubled Nebraska Plant
Pharmalot

Pfizer’s Read Finds Reason to Keep Consumer Health Unit

Pfizer’s Read Finds Reason to Keep Consumer Health Unit
Bloomberg

Reckitt in $482 mln deal to sell Bristol drugs in LatAm

Reckitt in $482 mln deal to sell Bristol drugs in LatAm
Reuters

Sanofi Buys Rolaids, Plans Product Relaunch in 2013

Sanofi Buys Rolaids, Plans Product Relaunch in 2013
Motley Fool

Merck KGaA to resist lure of potential proceeds from OTC sale

Merck KGaA to resist lure of potential proceeds from OTC sale
Reuters

Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium

Pfizer paying AstraZeneca $250M for rights to nonprescription version of heartburn drug Nexium
Yahoo/AP

Takeda: to sell J&J nonprescription brands in Japan

Takeda: to sell J&J nonprescription brands in Japan
Reuters

J&J ramping up OTC production as 'decree' work allows

J&J ramping up OTC production as 'decree' work allows
Fierce Pharma
Submitted by moderatorj on Mon, 06/04/2012 - 22:21

iTech Medical, Inc. Announces Upgrade in OTC Designation

iTech Medical, Inc. Announces Upgrade in OTC Designation
Yahoo/GlobeNewswire

Merck has no plans to sell animal and consumer health businesses

Merck has no plans to sell animal and consumer health businesses
NJ.com